论文部分内容阅读
公司名称行业地位投资要点研发实力较强,可获得国家支持。国家在生物领域提高政策扶持力度,以此来提高我国生物制药行业整体水平,具有研发实力的科华生物可享受到政策春风。在2007年12月底科华生物收到了国家发改委生物疫苗和诊断试剂专项补助资金300万元用于“艾滋病检测整体方案及其系列产品高技术产业化示范工程”。
Company Name Industry Status Investment Highlights R & D strength, access to state support. Countries in the field of biology to enhance policy support, in order to improve the overall level of China’s biopharmaceutical industry, with research and development strength Kehua biological policy can enjoy the breeze. At the end of December 2007, Kehua Bio-tech Co., Ltd. received a special subsidy of 3 million yuan from the National Development and Reform Commission for biological vaccines and diagnostic reagents for “the overall program of AIDS testing and its high-tech industrialization demonstration project”.